These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 168264)

  • 1. Analysis of sera from SV40-immunized and tumor-bearing hosts for blocking activity and antibody-dependent cellular cytotoxicity.
    Lausch RN; Sofranko J; Prather SO
    J Immunol; 1975 Sep; 115(3):682-7. PubMed ID: 168264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spleen cell-mediated cytotoxicity of hamster cells transformed by Herpes simplex virus: evidence for virus-specific membrane antigen.
    Lausch RN; Jones C; Christie D; Hay KA; Rapp F
    J Immunol; 1975 Jan; 114(1 Pt 2):459-65. PubMed ID: 163859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of SV40 tumor-mediated suppression of spleen cell cytotoxicity by antibody.
    Prather SO; Lausch RN
    J Immunol; 1977 Jan; 118(1):203-10. PubMed ID: 187698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inability of antiserum active in antibody-dependent cellular cytotoxicity and arming tests to protect against simian virus 40 tumor cell challenge.
    Prather SO; Geller RW; Lausch RN
    J Natl Cancer Inst; 1979 May; 62(5):1273-7. PubMed ID: 220449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization of BALB/c mice with recombinant simian virus 40 large tumor antigen induces antibody-dependent cell-mediated cytotoxicity against simian virus 40-transformed cells. An antibody-based mechanism for tumor immunity.
    Bright RK; Shearer MH; Kennedy RC
    J Immunol; 1994 Sep; 153(5):2064-71. PubMed ID: 8051411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro studies on the cellular immune response of tumor-bearing mice to SV40-transformed cells.
    Blasecki JW; Tevethia SS
    J Immunol; 1975 Jan; 114(1 Pt 1):244-9. PubMed ID: 163278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological studies with hamster cells transformed by cytomegalovirus and herpes simplex virus type 1.
    Lausch RN; Murasko DM; Jones C; Hay KA
    IARC Sci Publ (1971); 1975; (11 Pt 1):315-21. PubMed ID: 190134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the immunogenicity of hamster cells transformed by adenovirus and Herpes simplex virus.
    Thiry L; Sprecher-Goldberger S; Tack L; Jacques M; Stienon J
    Cancer Res; 1975 Apr; 35(4):1022-9. PubMed ID: 163694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo blocking of SV40 virus-induced antitumor resistance by Syrian hamster sera from early stages of primary SV40 carcinogenesis.
    Volpe EA
    Neoplasma; 1976; 23(4):345-53. PubMed ID: 187966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the specificity of in vitro induced lymphocytotoxicity to SV40-transformed fibroblasts.
    Warnatz H; Krapf F
    J Immunol; 1976 Sep; 117(3):981-5. PubMed ID: 182884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spleen-cell cytotoxicity for cytomegalovirus-transformed cells. II. Inhibition by cytomegalovirus antiserum.
    Murasko DM; Lausch RN
    Int J Cancer; 1975 Jul; 16(1):24-32. PubMed ID: 170214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of specific surface antigens on cells transformed by cytomegalovirus with the techniques of mixed hemagglutination and 125I-labeled antiglobulin.
    Lausch RN; Murasko DM; Albrecht T; Rapp F
    J Immunol; 1974 May; 112(5):1680-4. PubMed ID: 4361976
    [No Abstract]   [Full Text] [Related]  

  • 13. Development of nononcogenic SA7-adenovirus 2 populations that immunize against SA7-transformed cells.
    Kaplan PM; Melnick JL; Tevethia SS
    J Natl Cancer Inst; 1971 Mar; 46(3):565-76. PubMed ID: 4323136
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum factors modulating host immunity to SV40 tumor cells.
    Lausch RN; Prather SO
    Fed Proc; 1978 May; 37(7):2095-6. PubMed ID: 205443
    [No Abstract]   [Full Text] [Related]  

  • 15. Cellular immune response to virus-specific antigen in hamsters bearing isografts of cytomegalovirus-transformed cells.
    Murasko DM; Lausch RN
    Int J Cancer; 1974 Oct; 14(4):451-60. PubMed ID: 4142468
    [No Abstract]   [Full Text] [Related]  

  • 16. [Immunization of hamsters against tumors induced by the SV40 virus].
    Ciobanu Z; Fenyves A
    Arch Roum Pathol Exp Microbiol; 1970; 29(1):109-16. PubMed ID: 4328000
    [No Abstract]   [Full Text] [Related]  

  • 17. Sarcoma in a hamster inoculated with BK virus, a human papovavirus.
    Shah KV; Daniel RW; Strandberg JD
    J Natl Cancer Inst; 1975 Apr; 54(4):945-50. PubMed ID: 165302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humoral and cellular immune response during the growth of an SV40 induced tumour in hamsters.
    de Vaux Saint-Cyr C; Loisillier F; Zuinghedau J
    Ann Microbiol (Paris); 1977 Oct; 128(3):385-98. PubMed ID: 203215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune response of the Syrian golden hamster to SV40 induced and transplantable tumors.
    Goldrosen MH; Dent PB
    Fed Proc; 1978 May; 37(7):2092-5. PubMed ID: 205442
    [No Abstract]   [Full Text] [Related]  

  • 20. Cytotoxic action of spleen lymphocytes to simian virus 40-induced tumor cells.
    Egusa K
    Acta Med Okayama; 1973 Aug; 27(3):107-23. PubMed ID: 4357059
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.